XML 54 R32.htm IDEA: XBRL DOCUMENT v2.4.0.8
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Mar. 01, 2014
Summary of Significant Accounting Policies  
Schedule of revenues

 

 
  Year Ended  
 
  March 1,
2014
(52 Weeks)
  March 2,
2013
(52 Weeks)
  March 3,
2012
(53 Weeks)
 

Pharmacy sales

  $ 17,239,436   $ 17,083,811   $ 17,725,645  

Front end sales

    8,168,922     8,200,022     8,293,643  

Other revenue

    118,055     108,430     101,934  
               

 

  $ 25,526,413   $ 25,392,263   $ 26,121,222  
               
               
Schedule of principal classes of products

 

Product Class
  Percentage
of Sales
 

Prescription drugs

    67.9 %

Over-the-counter medications and personal care

    9.8 %

Health and beauty aids

    5.1 %

General merchandise and other

    17.2 %